Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
Medical oncology · Zhongshan Hospital · Shanghai

Dr. Zhu Xiaodong朱小东

Associate Chief Physician

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Zhu Xiaodong

Professional overview

Dr. Zhu Xiaodong is an Associate Chief Physician in the Department of Hepatobiliary Tumors and Liver Transplantation Surgery at Zhongshan Hospital. Dr. Zhu specializes in surgical treatment of liver and biliary malignancies and benign diseases, with expertise in laparoscopic minimally invasive surgery and downstaging followed by resection for advanced hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

SpecialtyMedical oncology
Clinical titleAssociate Chief Physician
Academic roles—
DepartmentDepartment of Hepatobiliary Tumors and Liver Transplantation Surgery
HospitalZhongshan Hospital
CityShanghai

Areas of focus

Surgical treatment of hepatocellular carcinoma and intrahepatic cholangiocarcinomaIncludes open and laparoscopic surgery for primary liver cancer (hepatocellular carcinoma, intrahepatic cholangiocarcinoma) and metastatic liver cancer (e.g., colorectal cancer, neuroendocrine tumors, gynecologic tumors)
Laparoscopic minimally invasive surgeryFor both malignant and benign hepatobiliary conditions, including hepatic hemangioma, focal nodular hyperplasia (FNH), and hepatic cysts
Downstaging and subsequent surgical resectionFor initially unresectable intermediate-to-advanced hepatocellular carcinoma and intrahepatic cholangiocarcinoma

Background

  • 2011Graduated from Fudan University with a Ph.D. in Surgery and joined Zhongshan Hospital for clinical work

Experience & recognition

  • Secretary for the National Health Commission's Guidelines for Diagnosis and Treatment of Primary Liver Cancer (2024 Edition)
  • Lead author of the Chinese Expert Consensus on Conversion Therapy for Hepatocellular Carcinoma (2021 Edition)
  • Editor of China's Pathway to Multidisciplinary Management of Hepatocellular Carcinoma
  • Principal investigator of one National Natural Science Foundation of China (NSFC) project and one Shanghai Natural Science Foundation project
  • First or co-first author of 20 SCI-indexed publications, including in Journal of Clinical Oncology, Liver Cancer, and Clinical Cancer Research; total impact factor >100; total citations >800
  • Second prize, Meidao Excellent Surgical Video Competition (National Level)
  • People's Good Doctor (Hepatobiliary Tumor Field), People's Health Network, People's Daily Online
  • Mead Johnson Life Sciences Award
  • Fudan University Academic Star
  • Shanghai Outstanding Doctoral Dissertation
  • EASL Young Investigator Award

Frequently asked questions

What does Dr. Zhu Xiaodong specialize in?

Surgical treatment of liver and biliary malignancies (including hepatocellular carcinoma, intrahepatic cholangiocarcinoma, gallbladder cancer, and colorectal cancer liver metastases), laparoscopic minimally invasive surgery for benign liver lesions (e.g., hepatic hemangioma, FNH, hepatic cysts), and downstaging followed by resection for unresectable intermediate-to-advanced liver cancer.

Which hospital and department is Dr. Zhu Xiaodong in?

Department of Hepatobiliary Tumors and Liver Transplantation Surgery at Zhongshan Hospital

Sources

Dr. Zhu Xiaodong has not reviewed this page.